Radian Q2 2026 slides: transformation complete but earnings miss

Radian Group shares fell 7.76% to $36.13 after Q2 2026 results: revenue rose 93% YoY to $575M (vs. $557.15M expected) but adjusted diluted net operating income per share fell to $1.14, missing consensus $1.34 by $0.20 (-14.9%). Specialty insurance now makes up 50% of revenue post-Inigo integration, yet profitability pressure persisted as the Specialty combined ratio came in at 97.7% including a $30M Middle East-related reserve charge; excluding it, management guided toward a high-80s/low-90s range. On capital, Radian declared $200M ordinary dividends, repurchased $76M, reduced its credit facility by $75M, and raised full-year dividend guidance to at least $650M while expecting specialty earned premiums to be ~20% higher in 2H26 than 1H26.

Analysis

RDN is no longer being traded like a clean mortgage insurer; it is now a two-engine balance-sheet story, and the market is discounting execution risk on the specialty side before giving credit for diversification. That matters because the acquisition has raised capital intensity just as the specialty market is softening, so even modest loss-ratio slippage can offset buybacks and keep the stock pinned near book. The immediate reaction looks more like a de-rating of the new earnings quality than a reassessment of franchise value.

The second-order winner is likely the pure-play mortgage insurer cohort, especially MTG and NMIH, which should screen better on capital return clarity and avoid reserve noise. By contrast, specialty/reinsurance names with recent M&A or opaque reserving could see sympathy pressure if investors start demanding a higher margin of safety. The contrarian read is that the selloff may be too aggressive if the reserve charge is truly one-off and mortgage defaults stay benign, because the core book still throws off capital and provides a cushion.

Key catalysts are over the next 1-3 months: specialty pricing, buyback pace, and any further commentary on capital buffer erosion. If repurchases slow or the cushion keeps shrinking, the equity will likely trade as a low-ROE capital return vehicle rather than a growth compounder over 6-18 months. The thesis breaks if specialty combined ratios stabilize in the low-90s without additional reserve surprises and management keeps the dividend/buyback machine running at the current pace.

Key Decisions for Investors

• Short RDN on strength into the post-earnings rebound zone over the next 1-2 weeks; risk is a quick relief rally if management clarifies the reserve as fully loaded and no additional charge follows.
• Pair trade: long MTG or NMIH / short RDN for 1-3 months to isolate the market’s preference for cleaner mortgage capital returns over integration-heavy diversification.
• Watchlist only: buy a 3-6 month RDN put spread if implied volatility is not already inflated; this is a tactical way to express further de-rating if specialty margins soften again.
• If RDN holds above the recent post-earnings low for two consecutive weeks and management reiterates buybacks near the top of guidance, cover shorts and reassess — that would signal the market has already priced the integration risk.